Carol Hill

2.3k total citations
22 papers, 257 citations indexed

About

Carol Hill is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Carol Hill has authored 22 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Applied Microbiology and Biotechnology, 7 papers in Molecular Medicine and 5 papers in Epidemiology. Recurrent topics in Carol Hill's work include Antibiotic Use and Resistance (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Carol Hill is often cited by papers focused on Antibiotic Use and Resistance (11 papers), Antibiotic Resistance in Bacteria (7 papers) and Bacterial Identification and Susceptibility Testing (5 papers). Carol Hill collaborates with scholars based in United States, United Kingdom and Japan. Carol Hill's co-authors include Warren J. Strittmatter, Scott Evans, Robin Patel, Robert A. Bonomo, Claudia Manca, Vance G. Fowler, Andrea M. Hujer, Henry F. Chambers, Barry N. Kreiswirth and Lauren Komarow and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and BMC Bioinformatics.

In The Last Decade

Carol Hill

19 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carol Hill United States	9	95	70	58	57	46	22	257
Madeline King United States	8	59 0.6×	132 1.9×	20 0.3×	85 1.5×	111 2.4×	17	330
Sharmila Khumra Australia	7	63 0.7×	20 0.3×	40 0.7×	33 0.6×	221 4.8×	16	313
Nicole Bonine United States	8	84 0.9×	90 1.3×	55 0.9×	60 1.1×	53 1.2×	20	286
Jonne J. Sikkens Netherlands	9	116 1.2×	10 0.1×	39 0.7×	48 0.8×	13 0.3×	26	347
Michaël Thy France	10	30 0.3×	36 0.5×	40 0.7×	114 2.0×	33 0.7×	47	364
Christy Varughese United States	9	33 0.3×	27 0.4×	24 0.4×	48 0.8×	257 5.6×	22	384
Valerie Cluzet United States	6	81 0.9×	7 0.1×	33 0.6×	54 0.9×	94 2.0×	25	209
Mohamad Chahine Russia	10	16 0.2×	74 1.1×	19 0.3×	33 0.6×	17 0.4×	19	260
Lucia Diella Italy	10	78 0.8×	156 2.2×	13 0.2×	73 1.3×	126 2.7×	28	329
Ana V. Pejčić Serbia	10	11 0.1×	19 0.3×	14 0.2×	29 0.5×	49 1.1×	42	334

Countries citing papers authored by Carol Hill

Since Specialization

Citations

This map shows the geographic impact of Carol Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Hill more than expected).

Fields of papers citing papers by Carol Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Hill. The network helps show where Carol Hill may publish in the future.

Co-authorship network of co-authors of Carol Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Hill. A scholar is included among the top collaborators of Carol Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Hill. Carol Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Komarow, Lauren, Jesse T. Jacob, Michael J. Satlin, et al.. (2025). 101. Patients with Carbapenem-resistant Klebsiella aerogenes and Enterobacter cloacae complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes. Open Forum Infectious Diseases. 12(Supplement_1).

Howard‐Anderson, Jessica, Toshimitsu Hamasaki, Lizhao Ge, et al.. (2025). 84. Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections. Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations

Boutzoukas, Angelique E, Natalie A Mackow, Lauren Komarow, et al.. (2024). Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections. Journal of Antimicrobial Chemotherapy. 79(11). 2916–2922. 2 indexed citations

Boutzoukas, Angelique E, Eric Cober, Lilian M. Abbo, et al.. (2024). Carbapenem-resistant Enterobacterales in solid organ transplant recipients. American Journal of Transplantation. 25(4). 848–859.

Iovleva, Alina, Christi L. McElheny, Eric Cober, et al.. (2024). In vitro activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant Acinetobacter baumannii collected in U.S. hospitals. Antimicrobial Agents and Chemotherapy. 68(3). e0125823–e0125823. 15 indexed citations

Howard‐Anderson, Jessica, Toshimitsu Hamasaki, Deborah Collyar, et al.. (2022). Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials. Clinical Infectious Diseases. 76(3). e1157–e1165. 15 indexed citations

Howard‐Anderson, Jessica, Dafna Yahav, Toshimitsu Hamasaki, et al.. (2022). A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection. Open Forum Infectious Diseases. 9(6). ofac140–ofac140. 9 indexed citations

Masci, Anna Maria, S. M. White, Mary-Anne Ardini, et al.. (2021). Ontology-guided segmentation and object identification for developmental mouse lung immunofluorescent images. BMC Bioinformatics. 22(1). 82–82. 1 indexed citations

Adekola, Josephine, Fabrice G. Renaud, & Carol Hill. (2021). Risk Information Sources for Snow Disaster Risk Preparedness in Scotland. International Journal of Disaster Risk Science. 12(6). 854–866. 4 indexed citations

10.

Evans, Scott, Thuy Tien T. Tran, Andrea M. Hujer, et al.. (2018). Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against Pseudomonas aeruginosa: PRIMERS IV. Clinical Infectious Diseases. 68(11). 1823–1830. 36 indexed citations

11.

Manca, Claudia, Carol Hill, Andrea M. Hujer, et al.. (2017). Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases. 64(suppl_1). S13–S17. 8 indexed citations

12.

Komarow, Lauren, Carol Hill, Thuy Tien T. Tran, et al.. (2016). Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group. Clinical Infectious Diseases. 64(suppl_1). S18–S23. 7 indexed citations

13.

Evans, Scott, Gene Pennello, Hongyu Jiang, et al.. (2016). Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME). Clinical Infectious Diseases. 63(6). 812–817. 21 indexed citations

14.

Evans, Scott, Thuy Tien T. Tran, Andrea M. Hujer, et al.. (2016). Choosing Ceftazidime/Avibactam and Ceftolozane/Tazobactam as Empiric Therapies against Pseudomonas aeruginosa (Pa) using Rapid Molecular Diagnostics (RMDs): PRIMERS IV. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations

15.

Evans, Scott E., Hongyu Jiang, Andrea M. Hujer, et al.. (2015). Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics (RMDs) to Identify Susceptibility and Resistance to Carbapenems Against Acinetobacter spp PRIMERS –III. Open Forum Infectious Diseases. 2(suppl_1). 4 indexed citations

16.

Hujer, Andrea M., Scott Evans, Hongyu Jiang, et al.. (2014). 608Can Rapid Molecular Diagnostics Assist in the Choice of b-Lactam Antibiotics? An Analysis of Data from PRIMERS-II of the Antibiotic Resistance Leadership Group (ARLG). Open Forum Infectious Diseases. 1(suppl_1). S28–S28. 1 indexed citations

17.

Rj, Harris, et al.. (2010). Increased detection of the HIV-1 reverse transcriptase M184V mutation using mutation-specific minority assays in a UK surveillance study suggests evidence of unrecognized transmitted drug resistance*. HIV Medicine. 12(4). 250–254. 15 indexed citations

18.

Brown, Alison, Gary Murphy, Gabriele Rinck, et al.. (2008). Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sexually Transmitted Infections. 85(1). 4–9. 6 indexed citations

19.

Strittmatter, Warren J. & Carol Hill. (2002). Molecular biology of apolipoprotein E. Current Opinion in Lipidology. 13(2). 119–123. 59 indexed citations

20.

Davies, Pamela, et al.. (1989). VIRGINIA FASTOLL -- VEHICLE IDENTIFICATION FOR NON-STOP TOLL COLLECTION. 1. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact